Cognitive Function During and After Treatment in Elderly Ovarian Cancer Patients

Abstract

Beyond the difficulties with attention, concentration and memory reported by cancer patients, it has become increasingly apparent that cytotoxic drugs given for non-central nervous system tumors might have side-effects on cognitive functioning. Nevertheless, in comparison to breast cancer patients, very few studies have concerned cognition in ovarian cancer patients despite the multiple courses of chemotherapy included in their management. Furthermore, no study has directly investigated elderly patients, even though age is a risk factor for ovarian cancer and cognitive impairment. Additional research is needed to apprehend the impact of cancer treatments on these women. Regarding oncologic practice, more detailed cognitive assessment of cognitively frail subjects would help oncologists to choose the most appropriate therapy.